4 March 2022 - Australian patients will have improved access to clinical trials due to reforms to be introduced by the Australian Government following advocacy by Medicines Australia and other groups.
The ‘National One Stop Shop’ and the ‘National Clinical Trials Front Door’ reforms have just completed the first phase of consultation with peak bodies Medicines Australia, AusBiotech, and the Medical Technology Association of Australia, via the R&D Taskforce.